An estimated 24 million Americans are living with an autoimmune disease, and another 8 million may eventually receive a diagnosis. It takes an average of 5 years for a patient to receive a diagnosis, leading to years of unnecessary specialty care, testing, and complications from misdiagnosis. Autoimmune disease is often diagnosed in the prime of an individual's life, when they are balancing demands of careers, family, and building financial security. A new diagnosis can be expensive, time-consuming, and financially devastating.
The scope of autoimmune disease is vast as there are over 100 autoimmune diseases, and many are poorly understood. As the second leading cause of chronic illness in the United States, autoimmune disease costs over $100 billion annually. Loss of productivity in the workforce has an additional and significant economic impact, with up to 50% of patients with rheumatoid arthritis unable to work within 10 years.
With a worsening shortage of specialists, persistently siloed care, and no single specialist overseeing autoimmune disease as a whole, the burden of care coordination often falls to the patient and can lead to poor health outcomes.
Aila Health aims to improve clinical outcomes for patients with autoimmune disease, decrease cost of care, and improve patient and provider satisfaction through an integrated, virtual specialty care model for autoimmune disease. By monitoring patient reported outcomes over time alongside clinical data, we can help patients coordinate care in one place, navigate a confusing set of symptoms, and have easier access to the right care at the right time, reducing unnecessary healthcare spend.
Our patients deserve better. Join us.